Skip to main content
Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Fig. 2

Kaplan-Maier overall survival curves of melanoma patient treated with nivolumab. a Patients stratified according baseline neutrophils-to lymphocyte ratio (NLR). Green line: NLR ≥ 5; Blue line: NLR < 5. b Patients stratified according baseline derived neutrophils-to lymphocyte ratio (dNLR). Green line: dNLR≥3; Blue line: dNLR< 3

Back to article page